How the digital environment can transform drug development space.
Jason Gagner (Vice President of Product for Life Science, PurpleLab) talks about clinical trial variables and how PurpleLab is working to maintain patient retention and accelerate site feasibility.
How the inclusion of measures centered on net treatment benefit can drive an effective multifaceted approach.
The approach of the Cancer Research UK Centre for Drug Development.
Renewed interest in psychedelic research shows great promise for patients in need of more effective therapies.
We are amidst a data revolution in healthcare and the life sciences. With advances in DNA sequencing, multiomics, wearables, imaging, and clinical data capture, there is more data — and there are more data modalities — to draw from for biomedical research than ever before. However, the quantity, variance and speed of data generation outpaces researchers’ ability to effectively utilize it to reveal medical breakthroughs for those in need. The ability to analyze health data is critical in developing a precision health approach. By leveraging diverse data sources, researchers can determine the most effective actions for individuals and communities. However, current barriers to data access and collaboration hinder progress. To accelerate the pace of discovery, a solution is needed to close the gap between research and health care. This paper describes how Verily Workbench provides solutions for healthcare professionals and researchers to easily access and collaborate on data within an integrated analysis and governance framework. Workbench provides a community of researchers with the platform, data, and tools to solve the most pressing scientific challenge
In light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.
Bringing clinical trials to patients’ homes can address existing site-based challenges.
Considering caregiver-supported trials to improve patient retention and outcomes.
To overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.
How optimizing RBQM risk detection reduces the efforts caused by false signals.
How Clinical Research Malaysia sped up CTA turnaround using a web-based system.
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
For advancement, pharma must focus on streamlining clinical operations.
Future shows great potential for neurological language assessments in clinical trials.
The success of the decentralized model hinges on coordination between stakeholders across the supply chain to ensure that date is secure, medication is delivered on time, and in proper condition.
Comparing late-stage COVID-19 vaccine trials to historical practices.
The patient recruitment and enrollment funnel is an overlooked pain point in clinical research. OneStudyTeam addresses inefficiencies in this stage, along with opportunities and strategies for improvement.
COVID-19 reshaping the roles of CRAs overseas as industry shifts to remote monitoring.
How today’s SSO reduces site burden and spearheads clinical system interoperability.
Study seeks to understand how different forms of data meet the needs of researchers.
Patient selection can be a nuanced process in clinical trials, particularly those involving therapeutic areas with more complex or subjective inclusion/exclusion criteria. Determining patient eligibility may often depend on factors that require clinical expertise in such areas as disease progression, comorbidities, genetic mutations, and disease severity. Discover the role eligibility adjudication committees play in ensuring trial success.
REMS are new only in name. The basic concept has long been central to drug regulation.
Knowing what you want from a CROs proposal will help make the most of the selection process.
A recent survey uncovers key criteria that influence a sponsor's decision when selecting a CRO.
Can the historical industry and vendor service relationship change to one where both parties benefit?
A recent survey uncovers key criteria that influence a sponsor's decision when selecting a CRO.